Analysis of human CD36 gene sequence alterations in the oxidized low-density lipoprotein-binding region using denaturing high-performance liquid chromatography

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 4, 2010, Pages 551-557

  Rać, Monika Ewa ^a   Suchy, Janina ^a   Kurzawski, Grzegorz ^a   Safranow, Krzysztof ^a   Jakubowska, Katarzyna ^a   Olszewska, Maria ^a   Garanty Bogacka, Barbara ^a   Rać, Michał ^a   Poncyljusz, Wojciech ^a   Chlubek, Dariusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; FATTY ACID; GENOMIC DNA; OXIDIZED LOW DENSITY LIPOPROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; HUMAN EXPERIMENT; INFANT; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANTIGENS, CD36; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COST-BENEFIT ANALYSIS; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; HUMANS; LIPOPROTEINS, LDL; NUCLEIC ACID DENATURATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN INTERACTION DOMAINS AND MOTIFS; SENSITIVITY AND SPECIFICITY;

EID: 77955866892     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0031     Document Type: Article

References (36)

1. Baillie AG, Coburn CT, Abumrad NA (1996) Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol 153:75-81.
2. Chilongola J, Balthazary S, Mpina M, et al. (2009) CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health 14:810-816.
3. Cotton RG, Bray PJ (2001) Using CCM and DHPLC to detect mutations in the glucocorticoid receptor in atherosclerosis: a comparison. J Biochem Biophys Methods 47:91-100.
4. Fasano T, Bocchi L, Pisciotta L, et al. (2005) Denaturing highperformance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency. J Lipid Res 46:817-822.
5. Fernandez-Ruiz E, Armesilla AL, Sanchez-Madrid F, et al. (1993) Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11.2. Genomics 17:759-761.
6. Frieda S, Pearce A, Wu J, et al. (1995) Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36. J Biol Chem 270:2981-2986.
7. Fry AE, Ghansa A, Small KS, et al. (2009) Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet 18:2683-2692.
8. Greenwalt DE, Lipsky RH, Ockenhouse CF, et al. (1992) Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80:1105-1115.
9. Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372.
10. Hanawa H, Watanabe K, Nakamura T, et al. (2002) Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency. J Med Genet 39:286-291.
11. Holinski-Feder E, Mü ller-Koch Y, Friedl W, et al. (2001) DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods 47:21-32.
12. Huszar D, Varban ML, Rinninger F, et al. (2000) Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20:1068-1073.
13. Imai M, Tanaka T, Kintaka T, et al. (2002) Genomic heterogeneity of type II CD36 deficiency. Clin Chim Acta 321:97-106.
14. Jones AC, Austin J, Hansen N, et al. (1999) Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 45: 1133-1140.
15. Kashiwagi H, Tomiyama Y, Honda S, et al. (1995) Molecular basis of CD36 deficiency. Evidence that a 478C?T substitution (proline90?serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 95:1040-1046.
16. Kashiwagi H, Tomiyama Y, Nozaki S, et al. (2001) Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum Genet 108:459-466.
17. Kintaka T, Tanaka T, Imai M, et al. (2002) CD36 genotype and long-chain fatty acid uptake in the heart. Circ J 66:819-825.
18. Kondo N, Honda S, Kuno S, et al. (2009) Positive association of common variants in CD36 with neovascular age-related macular degeneration. Aging 1:266-274.
19. Kurzawski G, Safranow K, Suchy J, et al. (2002) Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 51:89-100.
20. Lahiri DK, Schnabel B (1993) DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 31:321-328.
21. Leprêtre F, Vasseur F, Vaxillaire M, et al. (2004) A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes. Hum Mutat 24:104-110.
22. Love-Gregory L, Sherva R, Sun L, et al. (2008) Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 17:1695-1704.
23. Ma X, Bacci S, Mlynarski W, et al. (2004) A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 13:2197-2205.
24. Millat G, Chanavat V, Julia S, et al. (2009) Validation of highresolution DNA melting analysis for mutation scanning of the LMNA gene. Clin Biochem 42:892-898.
25. Nicholson AC, Han J, Febbraio M, et al. (2001) Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann NY Acad Sci 947:224-228.
26. Nozaki S, Tanaka T, Yamashita S, et al. (1999) CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled longchain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 192:129-135.
27. Park YM, Febbraio M, Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119:136-145.
28. Puente-Navazo MD, Daviet L, Ninio E, et al. (1996) Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol 16:1033-1039.
29. Rać ME, Safranow K, Poncyljusz W (2007) Molecular basis of human CD36 gene mutations. Mol Med 13:288-296.
30. Ren Y, Silverstein RL, Allen J, et al. (1995) CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 181:1857-1862.
31. Silverstein RL (2009) Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 76 Suppl2:S27-S30.
32. Tindall EA, Petersen DC, Woodbridge P, et al. (2009) Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments. Hum Mutat 30:876-883.
33. Vossen RH, Aten E, Roos A, et al. (2009) High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 30:860-866.
34. Yamamoto N, Akamatsu N, Sakuraba H, et al. (1994) Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 83:392-397.
35. Yanai H, Chiba H, Morimoto M, et al. (2000) Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am J Med Genet 93:299-304.
36. Zeng Y, Miao F, Li L, et al. (2007) A rapid and accurate DHPLC assay for determination of apolipoprotein E genotypes. J Alzheimers Dis 12:357-363.